PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193431
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193431
Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market with COVID-19 Impact Analysis, By Indication, By Treatment, End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size was valued at USD 5,207.3 Million in 2022, expanding at a CAGR of 8.8% from 2023 to 2030.
Breast cancer genes 1 and 2 (BRCA1 and BRCA2) contain instructions for inhibiting tumor cells or halting their unchecked growth. Additionally, these genes help to repair DNA damage. Mutations in the BRCA1 and BRCA2 genes can result in hereditary malignancies of the breast and ovarian. There may also be a rise in other malignancies like pancreatic and prostate cancer.
Market Dynamics
The global rise in cancer incidence and prevalence rates is what is driving the market. The American Cancer Society projects that in 2022, women in the United States will be diagnosed with 49,290 new instances of non-invasive breast cancer and 281,550 new cases of invasive breast cancer. A person's risk of acquiring certain malignancies increases if they inherit harmful mutations in one of these genes. Inheriting a harmful BRCA1 or BRCA2 mutation increases the risk of developing cancer at a younger age. The increasing costs of healthcare, which assist to improve its infrastructure, are a significant factor impacting the growth of the BRCA1 and BRCA2 genes market.
The breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) genes market will also grow as a result of increased initiatives by public and private organizations to disseminate awareness and technical advancement. Additionally, the market for the BRCA1 and BRCA2 genes will grow as a result of high disposable income and a constantly evolving lifestyle. A rise in the quantity of R&D activities is another factor driving the market's expansion. This will present advantageous chances for the market expansion of the BRCA1 and BRCA2 breast cancer genes. Further advantageous chances for the market expansion of the breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) genes will be provided by increased investment in the development of new technologies and an increase in the number of emerging markets.
Segmentation Analysis:
The Global Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market is segmented on the basis of Product, Treatment, End User, and Region.
The market is split into three categories based on Indication: breast cancer, ovarian cancer and others. The CRISPR segment dominates the market. Breast cancer concerns, treatments, therapy needs is mainly contributing to segment growth.
The market is segmented into four categories based on Treatment: platinum-based chemotherapy, PARP inhibitors, surgery and others. The platinum-based chemotherapy segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to a rise in the demand for chemotherapy in cancer treatment.
The market is segmented into four categories based on end user: hospitals, specialty clinics, homecare and others. The hospitals segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the number of breast cancer prevalence in adults is boosting the segment growth.
Competitive Landscape:
The worldwide market for Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes is widely fragmented in nature which comprised of large and small-sized market players with few large dominating the global market share. The companies in market emphasize on adopting aggressive strategies to reach out large consumer base. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new Product launches, partnerships, distribution network development, R&D spending, and mergers and acquisitions.
For instance, in March 2023, Sanofi started a study on evaluation of a menstruant in ER+/HER2- advanced or metastatic breast cancer.
Key features of the study:
This proposed research study on Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes market
Impact of COVID-19 on Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes market, we have also included competitive landscape and key innovator analysis for the Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BREAST CANCER 1 (BRCA1) AND BREAST CANCER 2 (BRCA2) GENES MARKET KEY PLAYERS
F. Hoffmann-La Roche Ltd.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Sun Pharmaceutical Industries Ltd.
AstraZeneca
Johnson & Johnson Private Limited
Merck & Co., Inc.
Akorn, Incorporated
Cipla Inc.
Pacira BioSciences, Inc.
Spectrum Pharmaceuticals, Inc
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Fresenius Kabi AG
GLOBAL BREAST CANCER 1 (BRCA1) AND BREAST CANCER 2 (BRCA2) GENES MARKET, BY INDICATION
Breast Cancer
Ovarian Cancer
Others
GLOBAL BREAST CANCER 1 (BRCA1) AND BREAST CANCER 2 (BRCA2) GENES MARKET, BY TREATMENT
Platinum-based Chemotherapy
PARP Inhibitors
Surgery
Others
GLOBAL BREAST CANCER 1 (BRCA1) AND BREAST CANCER 2 (BRCA2) GENES MARKET, BY END USER
Hospitals
Specialty Clinics
Homecare
Others
GLOBAL BREAST CANCER 1 (BRCA1) AND BREAST CANCER 2 (BRCA2) GENES MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
TABLE OF CONTENT
1. Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market Overview
- 1.1. Study Scope
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Market Snippet by Indication
- 2.1.2. Market Snippet by Treatment
- 2.1.3. Market Snippet by End User
- 2.1.4. Market Snippet by Country
- 2.1.5. Market Snippet by Region
- 2.2. Competitive Insights
3. Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Key Market Trends
- 3.1. Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Future Trends
4. Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market Landscape
- 6.1. Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market - By Indication
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
- 7.1.2. Breast Cancer
- 7.1.3. Ovarian Cancer
- 7.1.4. Others
8. Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market - By Treatment
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
- 8.1.2. Platinum-based Chemotherapy
- 8.1.3. PARP Inhibitors
- 8.1.4. Surgery
- 8.1.5. Others
9. Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market - By End User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
- 9.1.2. Hospitals
- 9.1.3. Specialty Clinics
- 9.1.4. Homecare
- 9.1.5. Others
10. Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. F. Hoffmann-La Roche Ltd.
- 11.2.2. Mylan N.V.
- 11.2.3. Teva Pharmaceutical Industries Ltd.
- 11.2.4. Sanofi
- 11.2.5. Pfizer Inc.
- 11.2.6. GlaxoSmithKline plc
- 11.2.7. Novartis AG
- 11.2.8. Sun Pharmaceutical Industries Ltd.
- 11.2.9. AstraZeneca
- 11.2.10. Johnson & Johnson Private Limited
- 11.2.11. Merck & Co., Inc.
- 11.2.12. Akorn, Incorporated
- 11.2.13. Cipla Inc.
- 11.2.14. Pacira BioSciences, Inc.
- 11.2.15. Spectrum Pharmaceuticals, Inc
- 11.2.16. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- 11.2.17. Fresenius Kabi AG
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market: Indication Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Indication
- TABLE Global Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Indication 2018-2030 (USD Million)
- TABLE Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market: Treatment Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Treatment
- TABLE Global Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Treatment 2018-2030 (USD Million)
- TABLE Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market: Regional snapshot (2022)
- TABLE Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market: End User Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by End User
- TABLE Global Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by End User 2018-2030 (USD Million)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Region 2018-2030 (USD Million)
- TABLE North America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Country, 2018-2030 (USD Million)
- TABLE North America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Indication, 2018-2030 (USD Million)
- TABLE North America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Treatment, 2018-2030 (USD Million)
- TABLE North America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by End User, 2018-2030 (USD Million)
- TABLE Europe Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Indication, 2018-2030 (USD Million)
- TABLE Europe Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Treatment, 2018-2030 (USD Million)
- TABLE Europe Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by End User, 2018-2030 (USD Million)
- TABLE Asia Pacific Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Indication, 2018-2030 (USD Million)
- TABLE Asia Pacific Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Treatment, 2018-2030 (USD Million)
- TABLE Asia Pacific Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by End User, 2018-2030 (USD Million)
- TABLE Latin America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Indication, 2018-2030 (USD Million)
- TABLE Latin America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Treatment, 2018-2030 (USD Million)
- TABLE Latin America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by End User, 2018-2030 (USD Million)
- TABLE Middle East and Africa Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Indication, 2018-2030 (USD Million)
- TABLE Middle East and Africa Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by Treatment, 2018-2030 (USD Million)
- TABLE Middle East and Africa Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market, by End User, 2018-2030 (USD Million)
List of Figures
- FIGURE Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2022
- FIGURE Indication segment market share analysis, 2022 & 2030
- FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Treatment segment market share analysis, 2022 & 2030
- FIGURE Treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE End User segment market share analysis, 2022 & 2030
- FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Regional segment market share analysis, 2022 & 2030
- FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE North America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market share and leading players, 2022
- FIGURE Europe Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market share and leading players, 2022
- FIGURE Asia Pacific Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market share and leading players, 2022
- FIGURE Latin America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market share and leading players, 2022
- FIGURE Middle East and Africa Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market share and leading players, 2022
- FIGURE North America market share analysis by country, 2022
- FIGURE U.S. Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Canada Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Europe Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market share analysis by country, 2022
- FIGURE Germany Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Spain Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Italy Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE France Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE UK Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Russia Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Netherlands Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Sweden Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Poland Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of the Europe Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Asia Pacific Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market share analysis by country, 2022
- FIGURE India Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE China Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Japan Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE South Korea Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Australia Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Thailand Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Indonesia Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Phillipines Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of APAC Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market share analysis by country, 2022
- FIGURE Brazil Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Mexico Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Argentina Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Colombia Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of LATAM Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market share analysis by country, 2022
- FIGURE Saudi Arabia Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE United Arab Emirates Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Israel Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Turkey Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Algeria Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Egypt Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of MEA Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
